Holen Sie sich die Stockscreener-App
1.19
0.00%
0.00
Handel nachbörslich:
1.19
Schlusskurs vom Vortag:
$1.19
Offen:
$1.19
24-Stunden-Volumen:
86,576
Relative Volume:
0.28
Marktkapitalisierung:
$61.77M
Einnahmen:
$1,000
Nettoeinkommen (Verlust:
$-14.25M
KGV:
-3.9548
EPS:
-0.3009
Netto-Cashflow:
$-11.29M
1W Leistung:
-0.83%
1M Leistung:
-11.85%
6M Leistung:
+35.12%
1J Leistung:
+141.53%
1-Tages-Spanne:
$1.18
$1.2199
1-Wochen-Bereich:
$1.17
$1.24
52-Wochen-Spanne:
$0.50
$1.57
Talphera Inc Stock (TLPH) Company Profile
Firmenname
Talphera Inc
Sektor
Telefon
650-216-3500
Adresse
1850 GATEWAY DRIVE, SAN MATEO
Compare TLPH vs TAK, HLN, TEVA, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TLPH
Talphera Inc
|
1.19 | 61.77M | 1,000 | -14.25M | -11.29M | -0.3009 |
TAK
Takeda Pharmaceutical Co Adr
|
18.24 | 57.90B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
10.16 | 43.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.93 | 42.89B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
77.17 | 31.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
512.88 | 22.35B | 3.17B | 1.29B | 1.01B | 27.09 |
Talphera Inc Stock (TLPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2020-07-20 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2019-11-11 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2019-07-10 | Fortgesetzt | Credit Suisse | Outperform |
| 2019-04-24 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-02-15 | Eingeleitet | Credit Suisse | Outperform |
| 2018-10-23 | Eingeleitet | B. Riley FBR | Buy |
| 2017-10-13 | Herabstufung | Jefferies | Buy → Hold |
| 2017-10-13 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-07-14 | Fortgesetzt | Jefferies | Buy |
| 2016-09-15 | Bestätigt | ROTH Capital | Buy |
| 2016-08-05 | Herabstufung | Stifel | Buy → Hold |
| 2015-10-30 | Hochstufung | Jefferies | Hold → Buy |
| 2015-10-05 | Bestätigt | ROTH Capital | Buy |
| 2015-09-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-07-10 | Fortgesetzt | ROTH Capital | Buy |
| 2015-05-06 | Bestätigt | Mizuho | Neutral |
| 2015-05-05 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-03-10 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-03-09 | Herabstufung | Mizuho | Buy → Neutral |
Alle ansehen
Talphera Inc Aktie (TLPH) Neueste Nachrichten
Talphera Inc. (NASDAQ: TLPH) Share Price, TLPH Stock News, TLPH Share Price & Updates - Kalkine
Talphera (TLPH) Move: Ends Up by 0.84% at $1.20 in the Latest Session; Next Test - vinanet.vn
Q1 2026 Talphera Inc Earnings Call Transcript - GuruFocus
Conferencia de resultados del T2 de 2026 de Talphera (TLPH): la inscripción en NEPHRO CRRT alcanza el 75 % - TradingKey
TLPH Q2 2026 Earnings: Narrower-Than-Expected Loss Delivers 11.76% EPS SurpriseDividend Growth Analysis - vinanet.vn
Talphera Inc (TLPH) Stock News Today - TradingKey
Talphera (TLPH) Gains 1.65% as Shares Approach Key Resistance at $1.29Ichimoku TK Cross - vinanet.vn
TLPH Q2 2026 Earnings: Narrower Loss Beats Estimates as Pre-Revenue Discipline HoldsEarnings Expansion Phase - vinanet.vn
HC Wainwright Has Negative View of Talphera FY2029 Earnings - MarketBeat
Talphera (TLPH) Q2 2026 Earnings Call: NEPHRO CRRT-Rekrutierung erreicht 75 % - TradingKey
Talphera (TLPH) Q2 2026 Earnings Call: NEPHRO CRRT Enrollment Reaches 75% - TradingKey
Talphera, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
H.C. Wainwright reiterates Talphera stock rating on trial progress - Investing.com
H.C. Wainwright reiterates Talphera stock rating on trial progress By Investing.com - Investing.com Canada
Talphera (TLPH) Advances NEPHRO CRRT Enrollment Amid Guideline S - GuruFocus
Talphera Inc (TLPH) (Q2 2026) Earnings Call Highlights: NEPHRO S - GuruFocus
Talphera Q2 Earnings Call Highlights - marketbeat.com
Talphera: Q2 Earnings Snapshot - AOL.com
Talphera Q2 loss narrows 40%, NEPHRO study 75% enrolled - scanx.trade
Earnings call transcript: Talphera Q2 2026 meets estimates as stock slips - Investing.com Canada
Transcript : Talphera, Inc., Q2 2026 Earnings Call, Aug 12, 2026 - marketscreener.com
Talphera (NASDAQ:TLPH) Issues Earnings Results, Meets Estimates - MarketBeat
Talphera Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Q2 2026 Talphera Inc Earnings Call Transcript - GuruFocus
TALPHERA, INC. 2026: Revenue $0 Net income ($4.31M), EPS ($0.06) — 10-Q Summary - TradingView
Talphera reports Q2 2026 net loss $4.3M, cash and investments $17.1M; NEPHRO CRRT 75% enrolled - TradingView
Talphera Announces Second Quarter 2026 Financial Results and Provides Corporate Update - PR Newswire
Talphera (TLPH): Rosalind entities report 9.9% beneficial ownership cap - Stock Titan
TLPH Q1 2026 Earnings: Narrower-Than-Expected Loss and Positive Stock MoveConsensus Miss Rate - vinanet.vn
Talphera Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
Talphera (NASDAQ:TLPH) Upgraded at Wall Street Zen - MarketBeat
Talphera Inc (TLPH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
TLPH Q1 2026 Earnings: 43.98% EPS Surprise Reflects Cost Discipline, But Shares Stay FlatRevenue Warning Signal - vinanet.vn
Talphera (TLPH.US) will release its earnings report after market close on August 12. - Moomoo
Enterprise value to EBIT forward of Talphera, Inc. – DUS:R5XA - TradingView
Talphera Inc. (TLPH) Climbs 5.93% to $1.43, Approaches Key $1.50 Resistance ZoneScalping Stock Signals - dars.gov.et
Talphera to Report Second Quarter 2026 Financial Results on Wednesday, August 12, 2026 - TradingView
Talphera schedules Q2 2026 results conference call and webcast - Bitget
TLPH Q1 2026 Earnings: Narrower-than-Expected Loss of $0.04 per ShareProfit Announcement - vinanet.vn
TLPH|Talphera Inc|Price:1.260|Chg%:-0.090 - TradingKey
Talphera (TLPH) Holds Near Key Support After Minor PullbackTrend Following Picks - vinanet.vn
Talphera, Inc. Revenue Breakdown – NASDAQ:TLPH - TradingView
Talphera Inc (TLPH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Talphera Inc (TLPH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Talphera Inc (TLPH) Income Statement - TradingKey
Talphera Inc (TLPH) Balance Sheet - TradingKey
Talphera Inc (TLPH) Cash Flow - TradingKey
Talphera Inc. (TLPH) Slips 6.67%, Testing Support as Biotech Sentiment WeakensTriple Bottom - dars.gov.et
Talphera Inc (TLPH) Institutional Confidence - TradingKey
Talphera Inc. (TLPH) Q1 2026 Earnings: Narrower-Than-Expected Loss as Pipeline Progress ContinuesDiluted EPS Report - dars.gov.et
TLPH|Talphera Inc|Price:1.350|Chg%:-0.020 - TradingKey
Finanzdaten der Talphera Inc-Aktie (TLPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
Talphera Inc-Aktie (TLPH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Angotti Vincent J. | CHIEF EXECUTIVE OFFICER |
Feb 12 '26 |
Buy |
0.81 |
105,364 |
85,587 |
586,954 |
| Aslam Shakil | Chief Medical Officer |
Feb 12 '26 |
Buy |
0.81 |
35,000 |
28,430 |
83,178 |
| Dasu Badri N | Chief Engineering Officer |
Feb 12 '26 |
Buy |
0.81 |
35,000 |
28,430 |
76,230 |
| ASADORIAN RAFFI | Chief Financial Officer |
Feb 12 '26 |
Buy |
0.81 |
45,000 |
36,554 |
91,256 |
1.12%
0.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):